Sandoz TV Episode 18: Trailer
Find out what to expect from the newest episode of Sandoz TV.
|Global News||Sandoz Around the World||Sandoz in the Media|
Sandoz Regional BioCamp winner finishes among top three in Basel
September 02, 2014
Janko Ignjatovic of Serbia has been selected as one of three individual winners of the Novartis International BioCamp held in Basel last week. Mr. Ignjatovic, who studies pharmacy at the University of Belgrade, came to the event through the Regional BioCamp, which took place in June and was organized by Lek, a Sandoz company.
Sandoz donates 25,000 units of benzathine penicillin to rheumatic heart disease study in Zambia
August 29, 2014
Life-saving medicines from Sandoz have arrived at the University Teaching Hospital in Lusaka, Zambia.
Sandoz Brazil introduces a new option for oncology patients
São Paulo, August 26, 2014
Sandoz, the generic pharmaceutical division of Novartis, today announces the market introduction in Brazil of the first generic version of oncology medicine bortezomibe.
Sandoz receives first approval in Latin America for innovative respiratory inhaler Airflusal® Forspiro®
Holzkirchen, August 20, 2014
Sandoz announces today that the Mexican Health Authority (COFEPRIS) has granted Sandoz marketing authorization for Airflusal® Forspiro®, an innovative new inhaler for patients with asthma and/or chronic obstructive pulmonary disease (COPD).
Sandoz Germany launches innovative new topical therapy for erectile dysfunction, a leading urological disorder
Holzkirchen, August 18, 2014
Sandoz, the generic pharmaceuticals division of Novartis, today announces the launch in Germany of Vitaros®, an innovative new topical therapy for erectile dysfunction (ED), one of the leading urological disorders in Europe and worldwide. Earlier this month, Sandoz launched Vitaros in Sweden.